Enhanced Antitumor Activity of Cetuximab in Combination with the Jak Inhibitor CYT387 against Non-Small-Cell Lung Cancer with Various Genotypes
Author:
Affiliation:
1. Department of Clinical Pharmacology, Pharmacy Care Center, Chinese PLA General Hospital, Beijing 100853, China
2. Department of Pharmacology and System Therapeutics, Mount Sinai School of Medicine; New York, New York 10029, United States
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.5b00927
Reference52 articles.
1. Inflammatory markers and the metabolic syndrome
2. Global Profiling and Molecular Characterization of Alternative Splicing Events Misregulated in Lung Cancer
3. Modeling of Tumor Progression in NSCLC and Intrinsic Resistance to TKI in Loss of PTEN Expression
4. The Optimal Chemotherapy for Stage III Non–Small Cell Lung Cancer Patients
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. IKBKE influences endometrial cancer growth and increases progestin resistance;American Journal of Clinical and Experimental Obstetrics and Gynecology;2024
2. Histone deacetylase inhibitors as sanguine epitherapeutics against the deadliest lung cancer;Advances in Cancer Research;2023
3. Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma;Head & Neck;2022-02-27
4. Taxus wallichiana var. chinensis (Pilg.) Florin Aqueous Extract Suppresses the Proliferation and Metastasis in Lung Carcinoma via JAK/STAT3 Signaling Pathway;Frontiers in Pharmacology;2021-11-16
5. CYT387, a potent IKBKE inhibitor, suppresses human glioblastoma progression by activating the Hippo pathway;Journal of Translational Medicine;2021-09-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3